Paper33639232
Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.
Lu J and 4 others. Pharmacol Res, 2021. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications. Papers, record 33639232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33639232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Methylation | Major topic |
| Diabetic Angiopathies | Major topic |
| Epigenesis, Genetic | Major topic |
| Histones | Major topic |
| Protein Processing, Post-Translational | Major topic |
| RNA, Untranslated | Major topic |
| Acetylation | |
| Animals | |
| Humans | |
| Methylation |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794851 | Epigenetic Regulation of Ferroptosis in Inflammation: Molecular Mechanisms and Therapeutic Perspectives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794851 | PubMed |
| 42469876 | Diabetic retinopathy: shaped by the "hidden hand" of post-translational modifications. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42469876 | PubMed |
| 42338726 | Progress in research on the association between glucose metabolism disorders and intracranial and extracranial atherosclerotic stenosis. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42338726 | PubMed |
| 41985902 | Serum LINC00861: A novel biomarker for diabetic nephropathy diagnosis and a promoter of renal injury via miR-378a-3p. | Diab Vasc Dis Res | 2026 | https://conductscience.org/library/papers/41985902 | PubMed |
| 41931346 | Association between life course adiposity and diabetic microvascular complications: A univariable and multivariable Mendelian randomization study. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/41931346 | PubMed |
| 41540054 | Improving erectile function in diabetic male mice by rescuing depalmitoylated FBP1 to reduce cavernosal lactate. | Nat Commun | 2026 | https://conductscience.org/library/papers/41540054 | PubMed |
| 41464680 | Precision Medicine in Diabetic Retinopathy: The Role of Genetic and Epigenetic Biomarkers. | J Clin Med | 2025 | https://conductscience.org/library/papers/41464680 | PubMed |
| 41194960 | Therapeutic Potential of hucMSC-EVs in Diabetic Kidney Disease via Regulating the miR-146b-5p/Merlin/YAP Axis. | Stem Cells Int | 2025 | https://conductscience.org/library/papers/41194960 | PubMed |
| 41064230 | CD44, ACAN, PLVAP, and HBEGF Emerged as Potential Biomarkers in Diabetic Retinopathy. | Diabetes Metab Syndr Obes | 2025 | https://conductscience.org/library/papers/41064230 | PubMed |
| 41024943 | Long non-coding RNAs promote colorectal cancer development through other epigenetic modifications. | Gastroenterol Rep (Oxf) | 2025 | https://conductscience.org/library/papers/41024943 | PubMed |
| 40989889 | Nanomaterial-Based Anti-Angiogenic Gene Therapy for Retinal Neovascular Diseases: Mechanistic Insights and Preclinical Advances. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40989889 | PubMed |
| 40844725 | Exploring the epigenetic mechanisms of recurrent pregnancy loss: from genetic predisposition to environmental influences. | J Assist Reprod Genet | 2025 | https://conductscience.org/library/papers/40844725 | PubMed |
| 40755747 | Advances in the Epigenetic Mechanisms of Diabetic Nephropathy Pathogenesis. | Diabetes Metab Syndr Obes | 2025 | https://conductscience.org/library/papers/40755747 | PubMed |
| 40585063 | Deciphering the multifaceted role of circular RNA in aging: from molecular mechanisms to therapeutic potentials. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/40585063 | PubMed |
| 40457447 | Unraveling the advances of non-coding RNAs on the tumor microenvironment: innovative strategies for cancer therapies. | J Transl Med | 2025 | https://conductscience.org/library/papers/40457447 | PubMed |
| 40244046 | DNA Methylation in Periodontal Disease: A Focus on Folate, Folic Acid, Mitochondria, and Dietary Intervention. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40244046 | PubMed |
| 40003672 | Enhancing Retinal Resilience: The Neuroprotective Promise of BDNF in Diabetic Retinopathy. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40003672 | PubMed |
| 39301658 | Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). | Int J Mol Med | 2024 | https://conductscience.org/library/papers/39301658 | PubMed |
| 38366290 | Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38366290 | PubMed |
| 38294727 | Lessons and Applications of Omics Research in Diabetes Epidemiology. | Curr Diab Rep | 2024 | https://conductscience.org/library/papers/38294727 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33639232
GET https://conductscience.org/api/papers/v1/33639232/cited_by?page=2